Case control analysis identifies infection risks in mastectomy patients, highlighting the need for better protocols.
Case control analysis of breast tissue expander (TE) infections after clinic-based expansion procedures from 2019 to 2022 in a large county hospital found no significant modifiable risk factors, including implant type. Suboptimal sterile access may be an independent contributor to TE infections following clinic procedures. Ongoing protocol adherence and monitoring are needed.
No takes yet. Share an insight, caveat, or question.
Ngo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: